Skip to main content
See every side of every news story
Published loading...Updated

FDA Authorizes New Treatment for Screwworm Infestations in Dogs

The prescription chewable is authorized for treatment only, after the FDA said evidence suggests benefits outweigh risks and no alternatives were available.

  • On Thursday, the FDA issued an emergency use authorization for Zoetis Inc.'s Simparica TRIO to treat New World screwworm infestations in dogs and puppies.
  • Originally approved in 2020 for heartworm, flea, and tick-related indications, Simparica TRIO received this new indication to provide additional treatment options during the public health threat.
  • Acting FDA Commissioner Kyle Diamantas, J.D. stated, "The FDA continues to authorize products to give veterinarians and pet owners multiple treatment options," noting the agency's containment success to date.
  • Timothy Schell, Ph.D., director of the FDA's Center for Veterinary Medicine, urged dog owners to stay informed rather than alarmed, noting NWS has only been detected in Texas and New Mexico.
  • Simparica TRIO is available only by prescription due to professional monitoring requirements, joining Elanco Animal Health's Credelio, which received an emergency use nod last year for the same indication.
Insights by Ground AI

20 Articles

Globe NewswireGlobe Newswire
+2 Reposted by 2 other sources
Center

FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Business Wire broke the news in Crystal River, United States on Thursday, August 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal